Cargando…
Hydroxychloroquine for the management of chronic chikungunya arthritis
Autores principales: | Nogueira, Igor Albuquerque, Cordeiro, Rafael Alves, Henn, Guilherme Alves de Lima, de Oliveira, Jobson Lopes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical de São Paulo
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115449/ https://www.ncbi.nlm.nih.gov/pubmed/37075333 http://dx.doi.org/10.1590/S1678-9946202365026 |
Ejemplares similares
-
The Effect of Hydroxychloroquine on Cardiovascular Disease in Patients with Rheumatoid Arthritis
por: Mo, De-Gang, et al.
Publicado: (2022) -
Post-Chikungunya Rheumatoid Arthritis, Saint Martin
por: Foissac, Maud, et al.
Publicado: (2015) -
Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis
por: Swarnakar, Raktim, et al.
Publicado: (2022) -
Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis
por: Zeppieri, Marco
Publicado: (2023) -
Viral metagenomics in nasopharyngeal swabs of Brazilian patients negative for SARS-CoV-2 unveils the presence of Chikungunya virus infection
por: Quintão, Tatyane de Souza Cardoso, et al.
Publicado: (2022)